Evidence map›Paper›PMID 34089169›Full record

ReviewPulmonary therapy2021

Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer.

Vittorio Gebbia, Aurelia Guarini, Dario Piazza, Alessandro Bertani, Massimiliano Spada, Francesco Verderame, Concetta Sergi, Enrico Potenza, Ivan Fazio, Livio Blasi and 16 more

Abstract readReview
In one paragraph

Review in Pulmonary therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. An IT Platform Supporting Rectal Cancer Tumor Board Activities: Implementation Process and Impact Analysis.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Vittorio GebbiaMedical Oncology Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, La Maddalena Clinic for Cancer, University of Palermo, Via San Lorenzo Colli n. 312D, 90100, Palermo, Italy. vittorio.gebbia@gmail.com.ORCID http://orcid.org/0000-0001-8406-9416
Aurelia GuariniMedical Oncology Unit, Fondazione Ospedale Giglio, Cefalù, Palermo, Italy.
Dario PiazzaGSTU Foundation, Palermo, Italy.
Alessandro BertaniDivision of Thoracic Surgery and Lung Transplantation, Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS Ismett, UPMC, Palermo, Italy.
Massimiliano SpadaMedical Oncology Unit, Fondazione Ospedale Giglio, Cefalù, Palermo, Italy.
Francesco VerderameMedical Oncology Unit, Ospedale Cervello Villa Sofia, Palermo, Italy.
Concetta SergiThoracic Surgery Unit, ARNAS, Ospedale Garibaldi, Nesima, Catania, Italy.
Enrico PotenzaThoracic Surgery Unit, ARNAS, Ospedale Garibaldi, Nesima, Catania, Italy.
Ivan FazioRadiation Therapy Unit, Clinica Macchiarella, Palermo, Italy.
Livio BlasiMedical Oncology Unit, Arnas Civico, Palermo, Italy.
Alba La SalaBronchial Endoscopy Unit, Arnas Civico, Palermo, Italy.
Gianluca MortillaroRadiation Therapy Unit, Arnas Civico, Palermo, Italy.
Elena RozPathology Unit, La Maddalena Clinic for Cancer, Palermo, Italy.
Roberto MarcheseThoracic Surgery Unit, La Maddalena Clinic for Cancer, Palermo, Italy.
Maurizio ChiarenzaMedical Oncology Unit, Istituto Clinico Humanitas, Catania, Italy.
Hector Soto-ParraMedical Oncology Unit, Policlinico, Catania, Italy.
Maria Rosaria ValerioMedical Oncology Unit, Policlinico, Palermo, Italy.
Giuseppe AgnetaThoracic Surgery Unit, Ospedale Cervello Villa Sofia, Palermo, Italy.
Carmela AmatoPatients Advocacy "Serena a Palermo", Palermo, Italy.
Helga LipariMedical Oncology Unit, Ospedale Cannizzaro, Catania, Italy.
Sergio BaldariNuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University Hospital G. Martino, Messina, Italy.
Francesco FerraùMedical Oncology Unit, Ospedale San Vincenzo, Taormina, Messina, Italy.
Alfio Di GraziaRadiation Oncology Unit, Istituto Clinico Humanitas, Catania, Italy.
Gianfranco MancusoMedical Oncology Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, La Maddalena Clinic for Cancer, University of Palermo, Via San Lorenzo Colli n. 312D, 90100, Palermo, Italy.
Sergio RizzoMedical Oncology Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, La Maddalena Clinic for Cancer, University of Palermo, Via San Lorenzo Colli n. 312D, 90100, Palermo, Italy.
Alberto FirenzeRisk Management Unit, Policlinico, University of Palermo, Palermo, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, the virtual multidisciplinary tumor boards (vMTBs) are increasingly used to achieve high-quality treatment recommendations across health-care regions, which expands and develops the local MTB team to a regional or national expert network. This review describes the process of lung cancer-specific MTBs and the transition process from face-to-face tumor boards to virtual ones. The review also focuses on the project organization's description, advantages, and disadvantages. Semi-structured interviews identified five major themes for MTBs: current practice, attitudes, enablers, barriers, and benefits for the MTB. MTB teams exhibited positive responses to modeled data feedback. Virtualization reduces time spent for travel, allowing easier and timely patient discussions. This process requires a secure web platform to assure the respect of patients' privacy and presents the same unanswered problems. The implementation of vMTB also permits the implementation of networks especially in areas with geographical barriers facilitating interaction between large referral cancer centers and tertiary or community hospitals as well as easier access to clinical trial opportunities. Studies aimed to improve preparations, structure, and conduct of MTBs, research methods to monitor their performance, teamwork, and outcomes are also outlined in this article. Analysis of literature shows that MTB participants discuss 5-8 cases per meeting and that the use of a vMTB for lung cancer and in particular stage III NSCLC and complex stage IV cases is widely accepted by most health professionals. Despite still-existing gaps, overall vMTB represents a unique opportunity to optimize patient management in a patient-centered approach.

Indexed as

Lung cancerMultidisciplinary tumor boardsOncology networksVirtualization

Identifiers

PMID34089169
PMCPMC8177259

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.